Search
for
Sort by
Research 181–210 of 1000+
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Minoxidil in the treatment of androgenetic alopecia
- Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16-29 years
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil in the treatment of female androgenetic alopecia
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Erosive pustular dermatosis of the scalp: a multicentre study
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients.
- THERAPEUTIC HOTLINE: Genetic variations in the androgen receptor gene and finasteride response in women with androgenetic alopecia mediated by epigenetics
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- CLINICAL AND NUTRITIONAL ASPECTS IN OBESE WOMEN DURING THE FIRST YEAR AFTER ROUX-EN-Y GASTRIC BYPASS
- Comprehensive Spectroscopic Characterization of Finasteride Polymorphic Forms. Does the Form X Exist?
- Acute telogen effluvium onset event is associated with the presence of female androgenetic alopecia: potential therapeutic implications
- Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Platelet rich plasma in androgenetic alopecia: A systematic review
- Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster
- Oral minoxidil bio‐activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss
- Tretinoin enhances minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes
- Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent
- Application of the basic and specific classification on patterned hair loss in Indians
- Thy1 marks a distinct population of slow-cycling stem cells in the mouse epidermis
- Minoxidil Sulfotransferase Enzyme (SULT1A1) genetic variants predicts response to oral minoxidil treatment for female pattern hair loss
- Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia
- Prevalence of hair shedding among women
- The medusa head: Dermoscopic diagnosis of woolly hair syndrome
- An open-label prospective observational study of antiandrogen and non-antiandrogen early pharmacological approaches in females with mild-to-moderate COVID-19. The Pre-AndroCoV Female Trial
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Frontal pattern hair loss among Chinese women is frequently associated with ponytail hairstyle
- Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.